Masato Shikami
Ise, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Bleeding due to acquired factor V inhibitor successfully treated with platelet transfusion during treatment for recurrent prostate squamous cell carcinoma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 08, 2022
High expression of c-Myc in chronic lymphocytic leukaemia with t(8;14)(q24.1;q32): A case report.
Journal: Leukemia research
Published: February 01, 2020
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).
Journal: International journal of clinical oncology
Published: September 04, 2018
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.
Journal: FEBS open bio
Published: April 16, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 30, 2017
Bone Marrow Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network Supporting Survival of Acute Monocytic Leukemia Cells.
Journal: Cancer research
Published: June 20, 2016
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.
Journal: International journal of hematology
Published: May 20, 2015
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 18, 2013
Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Journal: Oncology reports
Published: December 04, 2012
Last Updated: 09/26/2026